111 – 120 of 166
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Low-Level Viremia during ART and the Risk of Death, AIDS, and Serious Non-AIDS-events
(
- Contribution to conference › Abstract
-
Mark
Jugular Vein Thrombosis and Anticoagulation Therapy in Lemierre’s Syndrome—A Post Hoc Observational and Population-Based Study of 82 Patients
2020) In Open Forum Infectious Diseases(
- Contribution to journal › Article
-
Mark
A phase 2 randomized, double-blind, placebo-controlled trial of MHAA4549A, a monoclonal antibody, plus oseltamivir in patients hospitalized with severe influenza a virus infection
(
- Contribution to journal › Article
- 2019
-
Mark
Humoral response to Clostridium difficile in inflammatory bowel disease, including correlation with immunomodulatory treatment
(
- Contribution to journal › Article
-
Mark
Risk factors associated with prolonged intestinal colonization of ESBL-producing Enterobacteriaceae – a prospective cohort study
(
- Contribution to journal › Article
-
Mark
HIV-2 as a model to identify a functional HIV cure
(
- Contribution to journal › Scientific review
-
Mark
Plasma profiles of inflammatory markers associated with active tuberculosis in antiretroviral therapy-naive human immunodeficiency virus-positive individuals
(
- Contribution to journal › Article
-
Mark
Is low-level HIV-1 viraemia associated with elevated levels of markers of immune activation, coagulation and cardiovascular disease?
(
- Contribution to journal › Article
-
Mark
New insights are game-changers in HIV-2 disease management – Authors' reply
(
- Contribution to journal › Letter
-
Mark
Performance of Bio-Rad HIV-1/2 Confirmatory Assay in HIV-1, HIV-2 and HIV-1/2 dually reactive patients - comparison with INNO-LIA and immunocomb discriminatory assays
(
- Contribution to journal › Article